tweetindex
ES

CancerNetwork® ✓

@CancerNetwrk · Cranbury, NJ · joined 27 Feb 2009

Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.

30 129Followers
772Following
23 536Posts total
3.8KViews on collected posts

Últimas publicaciones

🚨 FDA approves Lutetium Lu 177 dotatate injection for patients with somatostatin receptor-positive GEP-NETs. #NETs #gicsm #radonc | @FDADrugs https://t.co/HaEvHZjIVm https://t.co/tGULRhjZMX
786 views · 2 likes · 1 reposts · 0 replies Open on X →
Daraxonrasib elicited activity in patients with previously treated advanced RAS-mutant NSCLC. 💠 31% ORR at 120 mg or less 💠 34% ORR at 160 mg to 220 mg 💠 37% ORR at 300 mg https://t.co/qajig9dkdW #lcsm #NSCLC #oncology #cancer 538 views · 1 likes · 0 reposts · 0 replies Open on X →
Data from the phase 3 DeLLphi-305 trial revealed that durvalumab/tarlatamab significantly improved overall survival as 1L maintenance in ES-SCLC. https://t.co/G4w7undN8T #lcsm #SCLC #oncology #cancer 527 views · 0 likes · 0 reposts · 0 replies Open on X →
The @FDA has approved aminolevulinic acid hydrochloride (Ameluz), a 10% topical gel, in combination with photodynamic therapy for patients with superficial basal cell carcinoma. This approval marks the first and only photodynamic therapy for the treatment of a skin cancer. Read
385 views · 2 likes · 0 reposts · 0 replies Open on X →
"Crown remains the crown." A thoracic oncologist ranks 5 lung cancer trials blind — and one keeps beating the rest. https://t.co/ixe9VV8ui1 #LungCancer #Oncology https://t.co/n50QCYO7tH
1.6K views · 2 likes · 3 reposts · 0 replies Open on X →

Frente a cuentas del mismo tamaño

5 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. por debajo de sus pares en alcance y en interacción.

Visualizaciones medianas538esta cuenta924mediana de 10K–100K
Alcance, %1.79%esta cuenta3.62%mediana de 10K–100K
Interacción, %0.38%esta cuenta1.52%mediana de 10K–100K
MétricaEsta cuentaMediana de 10K–100KProporción
Visualizaciones medianas por publicación5389240.58×
Alcance (visualizaciones ÷ seguidores)1.79%3.62%0.49×
Tasa de interacción0.38%1.52%0.25×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.6K11 Sep
38514 Sep
527
538
78615 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.45%11 Sep
0.52%14 Sep
0.00%
0.19%
0.38%15 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes38.9%7 in total
Reposts22.2%4 in total
Quotes11.1%2 in total
Bookmarks27.8%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Cuentas similares